In Israel, at the state level raises the question of the need to open a network of pharmacies hemp

The Ministry of Health plans to open a network of licensed pharmacies eligible for the retail trade hemp, which will provide consumers with an alternative to the organized private teams hemp producers, such as the well-known organization Tikum Olam, which is not only the largest supplier of medical cannabis in Israel, but also a leading company in the market of therapeutic marijuana .

Israel has historically been a world leader in the therapeutic use of psychoactive cannabis, to be precise, since 1964, when Dr. Rafael Meshulam opened, the active compound of cannabis, tetrahydrocannabinol (THC), and its properties. Now, more than 22 thousand people in the country have the permission from the Ministry of Health of Israel's consumption of medical cannabis, which they deliver specialized medical clinics involved the treatment of chronic pain. But recently these institutions have attracted a real storm of criticism, both from ordinary consumers as well as senior officials of the country after several hospitals refused to provide their patients psychoactive hemp, referring to the fact that their customers are "malingerers who want to get cannabis for recreational purposes. "

"The Association of Support therapy with Medical Cannabis" reports that it is ready to sue the clinic, who refuse to serve their patients. "I talk to dozens of patients every day," says the head of the Association of journalists Carney Edid. "These people are really suffering from chronic pain sensation associated with a number of serious diseases. I can vouch that among them there will certainly not malingerers."

In order to get the country's authorities have official permission to use cannabis for medical purposes, the potential consumer should, at least, a year be a registered patient clinic for pain therapy. Thus, during this period the patient should be offered all alternatives hemp as an analgesic, including opiate medications and surgical procedures, which could pose a risk to the patient's life and can cause further complications, even if successful operation. Year of such therapy and various treatments can cost a person in an amount exceeding $ 1,000. At the moment, the country's 7,350 registered medical cannabis users who are diagnosed with chronic pain sensation.

Despite the enormous number of difficulties associated with such a method of producing psychoactive cannabis clinics continue to claim that some of their patients may be malingerers who want to obtain cannabis for recreational purposes. Some clinics have become immediately inform their potential customers that they completely refuse from providing their patients access to medical cannabis. Other medical centers reported that they had no end of patients in need of psychoactive cannabis, so they had no opportunity to serve new customers.

Last summer, the Israeli Ministry of Health has reported that in response to such incidents, it is going to increase the number of physicians who are directly certified to prescribe to their patients recommendations on medical cannabis. Accordingly, the ministry plans to open a network of licensed pharmacies eligible for the retail trade hemp, which will provide consumers with an alternative to the organized private teams hemp producers, such as the well-known organization Tikum Olam, which is not only the largest supplier of medical cannabis in Israel, but also a leading company in the market of therapeutic marijuana.

"In modern medicine, the spread of drugs should be engaged in the pharmacy. The system is already used in the distribution of various heavy painkillers like morphine," she said about the organization of specialized pharmacies Deputy Health Minister of Israel, Mr. James Litsmanna. "Cannabis is a psychoactive drug in the same."

In favor of the opening of cannabis pharmacies spoke and the head of the "Society of Pharmacists of Israel," Miki Offer. "We need to separate the producers of cannabis from its distributors. Nowhere in the world, no other medicine or medical equipment is not supplied to final consumers directly to the manufacturer. So I think that would be fair and reasonable to provide consumers with medical cannabis independence from the manufacturer of hemp drugs. More of cultivators of cannabis are not certified pharmacists, so they can not identify, will not cause any consumption of cannabis are any side effects from their customers. A qualified pharmacist at a specialized pharmacy, on the contrary, be able to determine how psychoactive hemp will interact with other prescription drugs consumed by the patient ".